Ibsen Awards: Announcing Ibsen Scholarships 2021
Looking for funding for your performing arts project?
The Ibsen Scholarship program offers funding for innovative performing arts projects worldwide.
The scholarship program amounts to a total of NOK 2.000.000,- (approx. Euro 205.000 / USD 248.000).
The projects must act as incentives for critical discourses on society related matters and be based on one or more of Henrik Ibsen’s plays.
Ibsen Scholarships applications will be evaluated by an appointed jury.
For further information, statutes and application form see www.ibsenawards.com
Deadline for applications is April 30th 2021.
The Ibsen Scholarships were initiated by the Norwegian government in 2007 and will be awarded for the 11th time in 2021. Ibsen Scholarships have been awarded 39 projects in 27 countries. See all winners here: http://ibsenawards.com/scholarship/winners/
The winners of the Ibsen Scholarships 2021 will be invited to Ibsen Awards Festival at Teater Ibsen in Skien, Norway in 2022.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CA-ATTACKIQ13.4.2021 09:02:09 CEST | Press release
AttackIQ Appoints New General Manager and Vice President of EMEA and APJ Regions
ADVA13.4.2021 09:02:09 CEST | Press release
ADVA showcases 400ZR DCI solution with Acacia and Inphi
TEMENOS13.4.2021 09:02:09 CEST | Press release
BlueShore Financial Expands Relationship with Temenos to Further its Digital Transformation
COMPUTEX-TAIPEI13.4.2021 08:54:07 CEST | Press release
Acer, AMD, Arm, Intel, Micron, NXP, Qualcomm and Supermicro Confirm Participation in COMPUTEX 2021 Hybrid
ESHOPWORLD13.4.2021 08:03:35 CEST | Press release
eShopWorld Appoints Martim Avillez Oliveira as Chief Commercial Officer - EMEA and APAC
EPIENDO-PHARMACEUTICALS13.4.2021 08:02:35 CEST | Press release
EpiEndo Pharmaceuticals Announces Launch of First-in-Human Clinical Trial of a Non-Antibiotic Macrolide for the Treatment of Chronic Inflammatory Airway Diseases
BIOCORP13.4.2021 08:02:14 CEST | Press release
BIOCORP and ROCHE DIABETES CARE FRANCE Launch Mallya, an Innovative Medical Device to Better the Daily Life of Patients With Diabetes
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom